Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2005-12-19
2010-10-05
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C424S001810, C424S001850, C424S009100
Reexamination Certificate
active
07807135
ABSTRACT:
This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits.
REFERENCES:
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5525632 (1996-06-01), Obsumi et al.
patent: 5601801 (1997-02-01), Flanagan et al.
patent: 2003/0149250 (2003-08-01), Kung et al.
patent: 2006/0002853 (2006-01-01), Kung et al.
patent: 2006/0269474 (2006-11-01), Kung et al.
patent: 231432 (1985-12-01), None
patent: 60247244 (1985-12-01), None
International Search Report for International Application No. PCT/US05/45682, United States Patent and Trademark Office, Alexandria, VA, mailed on Jun. 1, 2006.
International Search Report for International Application No. PCT/US05/45683, United States Patent and Trademark Office, Alexandria, VA, mailed on Dec. 12, 2006.
Ager, I.R., and Phillips, L., “19F Nuclear Magnetic Resonance Studies of Aromatic Compounds. Part I. The Effect of Solvents on the Chemical Shift of Fluorine Nuclei inpara-Substituted Fluorobenzenes, 4-Substituted 4′-Fluoro-trans-stilbenes, and 4-Substituted 3′-Fluoro-trans-stilbenes,”J. Chem. Soc., Perkin Trans. II:1975-1982, 1993, The Chemical Society (1972).
Annunziata, R. And Colonna, S., “Stereochemistry of α-Halogeno-sulphoxides. Part 5. Absolute Stereochemistry of α-Chlorination of Benzyl t-Butyl Sulphoxide,”J. Chem. Soc., Perkin Trans. I:1052-1056, The Chemical Society (1977).
Arbez-Gindre, C., et al., “Organolithium reagents bearing nonlinear optical chromophores. Synthesis of triarylmethane dyes,”Tetrahedron Lett. 40:7413-7416, Elsevier Science Ltd. (1999).
Ashburn, T.T., et al., “Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides,”Chem. Biol. 3:351-358, Current Biology Ltd. (1996).
Attinà, M., et al., “Labeled Aryl Fluorides from the Nucleophilic Displacement of Activated Nitro Groups by18F-F,”J. Labelled Comp. Radiopharm. XX. 501-514, John Wiley & Sons, Ltd. (1983).
Berge, S.M. et al., “Pharmaceutical Salts,”J. Pharm. Sci. 66:1-19, American Pharmaceutical Association (1977).
Counsell, R.E., et al.,“Radioiodinated Estrogens and Antiestrogens as Potential Imaging Agents,”Curr. Top. Mol. Endocrinol. 4:107-113, Plenum Press (1976).
Diana, G.D., et al., “Antiviral Activity of Some β-Diketones. 4. Benzyl Diketones. In Vitro Activity against Both RNA and DNA Viruses,”J. Med. Chem. 21:889-894, American Chemical Society (1978).
Elhaddaoui, A., et al., “Competition of Congo Red and Thioflavin S Binding to Amyloid Sites in Alzheimer's Diseased Tissue,”Biospectroscopy 1:351-356, John Wiley & Sons Inc. (1995).
Findeis, M.A., “Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization,”Biochim. Biophys. Acta 1502:76-84, Elsevier Science B.V. (2000).
Gascoyne, J.M., et al., “Fluorine-19 Nuclear Magnetic Resonance Studies of Aromatic Compounds. Part 5. Transmission of Substituent Effects across Two Aromatic Rings connected by C—C and -C- Linkages,”J. Chem. Soc. Perkin Trans. II:1051-1057, The Chemical Society (1977).
Ginsberg, S.D., et al., “Molecular Pathology of Alzheimer's Disease and Related Disorders,” inCerebral Cortex, Peters, A. and Morrison, J.H., eds., Kluwer Academic/Plenum Publishers, New York, NY, pp. 603-654 (1999).
Golde, T.E., et al., “Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease,”Biochim. Biophys. Acta 1502:172-187, Elsevier Science B.V. (2000).
Han, H., et al., “Technetium Complexes for the Quantitation of Brain Amyloid,”J. Am. Chem. Soc. 118:4506-4507, American Chemical Society (1996).
Ho, T.-I., et al., “Novel Photochemical Rearrangement of Styrylfurans,”Angew. Chem. Int. Ed. Engl. 38:2558-2560, Wiley-VCH Verlag GmbH (1999).
Klunk, W.E., et al., “Quantitative Evaluation of Congo Red Binding to Amyloid-like Proteins with a Beta-pleated Sheet Conformation,”J. Histochem. Cytochem. 37:1273-1281, The Histochemical Society, Inc. (1989).
Klunk, W.E., et al, “Quantitative In Vitro NMR Analysis of Alzheimer's, Non-Alzheimer's Demented and Control Brain,”Biol. Psychiatry(Abstracts) 35:627, Abstract No. 44., Elsevier (1994).
Klunk, W.E., et al., “Chrysamine-G Binding to Alzheimer and Control Brain: Autopsy Study of a New Amyloid Probe,”Neurobiol. Aging16:541-548, Elsevier Science Ltd. (1995).
Klunk, W.E., et al., “Staining of AD and Tg2576 Mouse Brain with X-34, a Highly Fluorescent Derivative of Chrysamine G and a Potential In Vivo Probe for β-sheet Fibrils,”Abstr. Soc. Neurosci. 23:1638, Abstract No. 636.12, Society for Neuroscience (1997).
Kruijer, P.S., “Biodistribution of123I-Labeled 4-Hydroxytamoxifen Derivatives in Rats with Dimethylbenzanthracene-Induced Mammary Carcinomas,”Nucl. Med. Biol. 24:719-722, Elsevier Science Inc. (1997).
Kumari, N. et al., “Studies on Ylides Exclusive Formation of Olefins From Carbonyl Compounds on Treatment withpara-Bromo- andpara-Iodo-Benzylidenetriphenylarsenanes,”J. Organomet. Chem.96:237-241, Elsevier Sequoia S.A., Lausanne (1975).
Kuner, P. et al., “Controlling Polymerization of β-Amyloid and Prion-derived Peptides with Synthetic Small Molecule Ligands,”J. Biol. Chem. 275:1673-1678, The American Society for Biochemistry and Molecular Biology, Inc. (2000).
Kung, H.F., “Novel Stilbenes as Probes for Amyloid Plaques,”J. Am. Chem. Soc. 123:12740-12741, American Chemical Society (2001).
Lee, C-W. et al., “Isomerization of (Z,Z) to (E,E)1-Bromo-2,5-bis-(3- hydroxycarbonyl-4-hydroxy)-styrylbenzene in Strong Base: Probes for Amyloid Plaques in the Brain,”J. Med. Chem. 44:2270-2275, American Chemical Society (2001).
Lorenzo, A., and Yankner, B.A., “β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red,”Proc. Natl. Acad. Sci. USA91:12243-12247, National Academy Press (1994).
Mathis, C.A. et al., “Synthesis of a Lipophilic, Radioiodinated Ligand with High Affinity to Amyloid Protein in Alzheimer's Disease Brain Tissue,”J. Labelled Comp. Radiopharm. 40:94-95, John Wiley & Sons, Ltd. (1997).
Moore, C.L. et al., “Difluoro Ketone Peptidomimetics Suggest a Large S1 Pocket for Alzheimer's γ-Secretase: Implications for Inhibitor Design,”J. Med. Chem. 43:3434-3442, American Chemical Society (2000).
Näslund, J. et al, “Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline,”J. Am. Med. Assoc. 283:1571-1577, American Medical Association (2000).
Selkoe, D.J. “Biology of β-Amyloid Precursor Protein and the Mechanism of Alzheimer Disease,” inAlzheimer Disease, 2ndedition, Terry, R.D. et al., eds., Lippincott Williams & Wilkins, Philadelphia, PA, pp. 293-310 (1999).
Selkoe, D.J., “The Origins of Alzheimer Disease. A is for Amyloid,”J. Am. Med. Assoc. 283:1615-1617, American Medical Association (2000).
Skovronsky, D.M., and Lee, V. M.-Y., “β-Secretase revealed: starting gate for race to novel therapies for Alzheimer's disease,”Trends Pharmacol. Sci. 21:161-163, Elsevier (2000).
Vassar, R. et al., “β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE,”Science286:735-741, American Association for the Advancement of Science (1999).
Vogelsberg-Ragaglia, V., et, al., “Cell Biology of Tau and Cytoskeletal Pathology in Alzheimer Disease,” inAlzheimer Disease, 2ndedition, Terry, R
Kung Hank F.
Kung Mei-Ping
Zhuang Zhi-Ping
Jones D L
The Trustees of the University of Pennsylvania
Woodcock & Washburn LLP
LandOfFree
Stilbene derivatives and their use for binding and imaging... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stilbene derivatives and their use for binding and imaging..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stilbene derivatives and their use for binding and imaging... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157254